Funding for this research was provided by:
Welch Foundation (E-1794)
Article History
Received: 27 February 2019
Accepted: 4 March 2019
First Online: 26 March 2019
Compliance with ethical standards
:
: J.R.A. and J.D.R. have filed patent applications on the use of hydroxycitrate and other modifiers as growth inhibitors of pathological calcification.